Analysts predict that Medical Properties Trust, Inc. (NYSE:MPW) will report $197.62 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Medical Properties Trust’s earnings, with the highest sales estimate coming in at $207.09 million and the lowest estimate coming in at $181.65 million. Medical Properties Trust posted sales of $176.58 million during the same quarter last year, which would indicate a positive year over year growth rate of 11.9%. The business is expected to issue its next quarterly earnings results on Thursday, November 1st.

According to Zacks, analysts expect that Medical Properties Trust will report full year sales of $807.51 million for the current year, with estimates ranging from $760.06 million to $836.00 million. For the next fiscal year, analysts anticipate that the business will post sales of $824.01 million per share, with estimates ranging from $761.07 million to $890.00 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Thursday, August 2nd. The real estate investment trust reported $0.30 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.36 by ($0.06). The business had revenue of $201.90 million during the quarter, compared to the consensus estimate of $206.72 million. Medical Properties Trust had a return on equity of 9.12% and a net margin of 44.46%. The firm’s revenue was up 21.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 earnings per share.

Several research analysts recently issued reports on the stock. Zacks Investment Research upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, May 9th. Wells Fargo & Co raised their price objective on shares of Medical Properties Trust from $11.50 to $13.00 and gave the company an “underperform” rating in a research note on Thursday, May 31st. Finally, Jefferies Financial Group lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating and set a $15.00 price objective for the company. in a research note on Tuesday, July 17th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $14.07.

Shares of Medical Properties Trust stock traded down $0.40 during trading on Tuesday, hitting $14.38. The company’s stock had a trading volume of 2,876,497 shares, compared to its average volume of 1,651,487. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.19 and a quick ratio of 2.04. The firm has a market cap of $5.39 billion, a price-to-earnings ratio of 10.41, a PEG ratio of 2.81 and a beta of 0.73. Medical Properties Trust has a 52 week low of $11.82 and a 52 week high of $14.92.

In other Medical Properties Trust news, insider R Steven Hamner sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $14.73, for a total transaction of $515,550.00. Following the sale, the insider now owns 1,114,044 shares in the company, valued at approximately $16,409,868.12. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Michael G. Stewart sold 3,409 shares of the firm’s stock in a transaction that occurred on Tuesday, August 7th. The stock was sold at an average price of $14.76, for a total transaction of $50,316.84. Following the sale, the director now owns 243,439 shares in the company, valued at approximately $3,593,159.64. The disclosure for this sale can be found here. 0.83% of the stock is currently owned by company insiders.

Several institutional investors have recently added to or reduced their stakes in MPW. Signaturefd LLC bought a new stake in shares of Medical Properties Trust during the first quarter valued at approximately $102,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in shares of Medical Properties Trust during the second quarter valued at approximately $104,000. Smith Asset Management Group LP raised its position in shares of Medical Properties Trust by 93.4% during the first quarter. Smith Asset Management Group LP now owns 8,351 shares of the real estate investment trust’s stock valued at $108,000 after buying an additional 4,032 shares during the last quarter. Integrated Investment Consultants LLC bought a new stake in shares of Medical Properties Trust during the second quarter valued at approximately $136,000. Finally, Investors Asset Management of Georgia Inc. GA ADV bought a new stake in shares of Medical Properties Trust during the second quarter valued at approximately $140,000. Hedge funds and other institutional investors own 78.22% of the company’s stock.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Further Reading: Diversification Important in Investing

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.